Oncology
 |
|
25 may 2018 06:00:04 |
| Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials (British Journal of Cancer) |
|
Tweet |
| 78 viewsCategory: Oncology |
 The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma (British Journal of Cancer)Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer (British Journal of Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
